Saba Capital Management, L.P. sold HQL
February 26, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 200 shares of Abrdn Life Sciences Investors at $13.62 per share, a transaction worth $2.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$13.62
Total value
$2.7K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 26, 2025
Filing dateFebruary 27, 2025
Shares owned after3,275,881
OwnershipIndirect
10b5-1 planNo
AmendedNo